A study to study the efficacy of Coleus aromatics extract nebulisation in Bronchial asthma

A Clinical Trial to evaluate the Shwasahara Karma of Parnayavani Arka (Coleus aromaticus Benth.)nebulization in the management of Tamaka Shwasa (Bronchial asthma). - SK-PY

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012339

Enrollment

Registered

2018-03-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Tamaka Shwasa - Acute exacerbation of Bronchial Asthma

Interventions

Intervention1: Parnayavani (Coleus aromaticus) Arka: 5ml Arka (aqueous distillate) is administered single time via nebulisation. Control Intervention1: Theophylline nebulization: 5ml of Theophylline i

Eligibility

Inclusion criteria

Inclusion criteria: PEFR: 60-90% conscious and well oriented Previously diagnosed cases of bronchial asthma Those patients who are ready to sign the informed consent form

Exclusion criteria

Exclusion criteria: PEFR less than 40% Patients with a history of Tuberculosis, Emphysema, Chronic airway limitation History of cardiac disease History of any other complicated respiratory diseases/having any organic lesions such as a tumour or any anatomical defect in the airway Cyanosis Hypertension (above 160mm Hg) Uncontrolled Diabetes mellitus (FBS greater than 126mg/dl)

Design outcomes

Primary

Measure	Time frame
peak expiratory flow rateTimepoint: 0 hour, just after nebulization and 1 hour after nebulisation	—

Secondary

Measure	Time frame
Subjective feelingTimepoint: Just before, during, and 1 hour after nebulisation	—

Countries

India

Contacts

Public ContactDr Pushya A Gautama

SDM College of Ayurveda and Hospital, Hassan

drharini@sdmcahhassan.org9886427831

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026